Correlation of QTc Interval ­Prolongation and Serum Level of Citalopram after Intoxication – A Case Report

Abstract

Citalopram (CIT) is a widely used antidepressant which acts by a selective serotonin reuptake inhibition. It is considered to be safer than tricyclic antidepressants at therapeutic levels, but also with respect to intoxications. We report the case of a 46-year-old woman, who ingested in suicidal intention 1400 mg CIT. During the following inpatient treatment repeatedly ECGs and determinations of the serum level of CIT were performed. Initially the patient’s serum level of CIT was 1231 ng/mL and QTc interval was 541.60 ms. It took 12 days until the serum level of CIT fell below the upper threshold of the recommended therapeutic range (130 ng/mL). The QTc interval on the sixth day after the intoxication for the first time was below 500 ms. The QTc interval correlated significantly with the serum level of CIT after intoxication (r=0.943; p<0.005). Although CIT is estimated as a safe antidepressant regarding serious adverse effects, toxic doses can lead to potentially hazardous ECG changes which according to our findings correlate strongly with the serum level of the drug.

Key words

citalopram - QTc - intoxication - serum level - therapeutic drug monitoring

• References

• 1 Brøsen K, Naranjo CA. Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram. Eur Neuropsychopharmacol 2001; 11: 275-283
• 2 Drasch G, Dahlmann F, von Meyer L et al. Frequency of different anti-depressants associated with suicides and drug deaths. Int J Legal Med 2008; 122: 115-121
• 3 Flanagan RJ. Fatal toxicity of drugs used in psychiatry. Hum Psychopharmacol Clin Exp 2008; 23: 43-51
• 4 Hawton K, Bergen H, Simkin S et al. Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. Br J Psychiatry 2010; 196: 354-358
• 5 van Noord C, Straus SM, Sturkenboom MC et al. Psychotropic drugs associated with corrected QT interval prolongation. J Clin Psychopharmacol 2009; 29: 9-15
• 6 Kelly CA, Dhaun N, Laing WJ et al. Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol 2004; 42: 67-71
• 7 Catalano G, Catalano MC, Epstein MA et al. QTc interval prolongation associated with citalopram overdose: a case report and literature review. Clin Neuropharmacol 2001; 24: 158-162
• 8 Personne M, Persson H, Sjoberg G. Citalopram toxicity. Lancet 1997; 350: 518-519
• 9 Personne M, Sjoberg G, Persson H. Citalopram overdose: review of cases treated in Swedish hospitals. J Toxicol Clin Toxicol 1997; 35: 237-240
• 10 Isbister GK, Bowe SJ, Dawson A et al. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004; 42: 277-285
• 11 Grundemar L, Wohlfart B, Lagerstedt C et al. Symptoms and signs of severe citalopram overdose [letter]. Lancet 1997; 349: 1602
• 12 Öström M, Eriksson A, Thorson J et al. Fatal overdose with citalopram. Lancet 1996; 348: 339-340
• 13 Hale AS. Citalopram is safe [letter]. Br Med J 1998; 316: 1825
• 14 Glassman AH. Citalopram toxicity [letter]. Lancet 1997; 350: 818
• 15 Waring WS, Gray JA, Graham A. Predictive factors for generalized seizures after deliberate citalopram overdose. Br J Clin Pharmacol 2008; 66: 861-865
• 16 Friberg LE, Isbister GK, Duffull SB. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br J Clin Pharmacol 2005; 61: 177-190
• 17 Baumann P, Hiemke C, Ulrich S et al. The AGNP-TDM Expert Group. Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry. Pharmacopsychiatry 2004; 37: 243-265
• 18 Pedersen OL, Gram LF, Kristensen CB et al. Overdosage of antidepressants: clinical and pharmacokinetic aspects. Eur J Clin Pharmacol 1982; 23: 513-521
• 19 Jimmink A, Caminada K, Hunfeld NG et al. Clinical toxicology of citalopram after acute intoxication with the sole drug or in combination with other drugs: overview of 26 cases. Ther Drug Monit 2008; 30: 365-371
• 20 Unverir P, Atilla R, Karcioglu O et al. A retrospective analysis of antidepressant poisonings in the emergency department: 11-year experience. Hum Exp Toxicol 2006; 25: 605-612
• 21 Hayes BD, Klein-Schwartz W, Clark RF et al. Comparison of toxicity of acute overdoses with citalopram and escitalopram. J Emerg Med 2010; 39: 44-48
• 22 Baranchuk A, Simpson CS, Methot M et al. Corrected QT interval prolongation after overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines. Can J Cardiol 2008; 24: 38-40
• 23 Rasmussen SL, Overo KF, Tanghoj P. Cardiac safety of citalopram: prospective trials and retrospective analyses. J Clin Psychopharmacol 1999; 19: 407-415
• 24 Witchel HJ, Pabbathi VK, Hofmann G et al. Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents. FEBS Lett 2002; 512: 59-66
• 25 Pacher P, Ungvari Z, Nanasi PP et al. Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?. Curr Med Chem 1999; 6: 469-480
• 26 Slavícek J, Paclt I, Hamplová J et al. Antidepressant drugs and heart electrical field. Physiol Res 1998; 47: 297-300
• 27 Hamplová-Peichlová J, Krůsek J, Paclt I et al. Citalopram inhibits L-type calcium channel current in rat cardiomyocytes in culture. Physiol Res 2002; 51: 317-321